← Medication Database
Other Specialties

VOXZOGO

Generic: vosoritide

Manufacturer: BioMarin Pharmaceutical Inc.  ·  Program: BioMarin RareConnections - VOXZOGO Co-Pay Assistance Program

Apply for Assistance

Eligibility Criteria

Insurance Requirement

Commercial prescription insurance coverage required; not valid for Medicare, Medicare Advantage, Medigap, Medicaid, VA, DoD, TRICARE, or cash-paying patients

Residency

United States and Puerto Rico

Program Information

Processing Time

2–4 weeks

Delivery Method

specialty pharmacy and home delivery coordination

Application Method

Multiple

Reauthorization

Required — annual

Typically Required Documents

ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.

  • Valid prescription for FDA-approved indication
  • Proof of commercial insurance coverage
  • Patient enrollment form

Indicated For

Achondroplasia

About This Medication

# BioMarin RareConnections - VOXZOGO Co-Pay Assistance Program Patient Guide: How to Get VOXZOGO at Low or No Cost VOXZOGO (vosoritide) is a prescription medication designed to increase linear growth in pediatric patients with achondroplasia who have open epiphyses. The **BioMarin RareConnections - VOXZOGO Co-Pay Assistance Program** helps eligible commercially insured patients reduce out-of-pocket costs for VOXZOGO, covering co-pays and potentially making treatment low or no cost.[1][2][3] ## About VOXZOGO and Achondroplasia Achondroplasia is the most common form of dwarfism, caused by a genetic mutation affecting bone growth. Children with achondroplasia often experience shorter stature and related complications like sleep apnea or spinal issues. **VOXZOGO** works by mimicking a natural hormone called C-type natriuretic peptide (CNP), which helps regulate bone growth. It's given as a daily subcutaneous injection at home, with dosage adjusted based on the child's weight. Treatment continues until the growth plates (epiphyses) close, typically in late adolescence. Caregivers must be trained on proper injection technique by a healthcare provider or BioMarin Clinical Coordinator.[1][5][8] Regular monitoring every 3-6 months is essential to track growth, weight, and development. Over 96% of eligible commercially insured patients have secured coverage for VOXZOGO through BioMarin RareConnections support.[1][5] ## Who Qualifies for the Program? This co-pay assistance is for patients with **commercial prescription insurance** who meet these criteria: - Valid prescription for VOXZOGO for FDA-approved use (pediatric achondroplasia with open epiphyses). - Proof of commercial insurance coverage. - Completion of enrollment forms. **Not eligible:** Patients with Medicare, Medicare Advantage, Medigap, Medicaid, VA, DoD, TRICARE, or those paying cash. If you switch to government-funded coverage, you must notify the program immediately to stop participation.[3] ## Income Eligibility Breakdown The program does not list specific income thresholds, making it accessible to a broad range of commercially insured patients. Eligibility focuses on insurance type rather than income. Here's a summary: | Eligibility Factor | Details | Status | |--------------------|---------|--------| | **Income Limits** | None specified; no FPL-based restrictions | Open to all qualifying insured patients[program data] | | **Insurance Type** | Commercial only | Required | | **Government Plans** | Medicare, Medicaid, etc. | Excluded | | **Cash Pay** | No assistance | Excluded | Contact BioMarin RareConnections for personalized eligibility review.[2][3] ## Insurance Requirements **Commercial prescription insurance is required.** The program helps navigate prior authorizations (PAs)—over 70% get approved on the first try with Case Manager support. BioMarin verifies benefits, assists with appeals, and coordinates with specialty pharmacies. If coverage is denied initially, Case Managers educate your doctor's office and help resubmit.[1][5] ## Step-by-Step Application Process Enrollment is simple and takes two main steps. Multiple methods are available: phone, fax, or digital forms.[1][2][4][5] 1. **Discuss with Your Doctor:** Confirm VOXZOGO is right for your child. Your doctor writes the prescription via the **Patient Enrollment Form (PEF)**, which includes insurance details (e.g., Member ID, RxBIN/PCN/Group) and authorizes BioMarin to handle reimbursement and pharmacy transmission.[4] 2. **Complete Patient Consent Form (PCF):** Sign to allow BioMarin, your doctor, and insurer to share info. This authorizes support services like benefit verification and education. Valid for 10 years or per state law.[2][4] 3. **Submit Forms:** Doctor faxes PEF to 1-888-863-3361. You complete PCF (often at the doctor's office or via email). Call **1-833-869-9646** (or 1-866-906-6100) for help, M-F 8AM-8PM ET.[1][4] 4. **Connect with Your Team:** A **Case Manager** verifies insurance, discusses co-pay options, and handles PA/appeals. A **Clinical Coordinator** trains on injections, coordinates delivery, and provides adherence tips (in-person, phone, text, email).[1][2] 5. **Enroll in Co-Pay Program:** Once eligible, activate co-pay assistance to lower costs. Download flyers for details.[2] ## Timeline and Delivery Processing time varies by insurance but is streamlined: Case Managers reach out soon after forms are submitted. PAs often approve quickly (70% first try), with >96% ultimate success.[1][5] Medication ships via **specialty pharmacy with home delivery coordination**. Expect ongoing support to avoid treatment gaps.[2][9] **Reauthorization is required** periodically, as dosage adjusts with weight and treatment continues until epiphyses close.[1] ## Alternatives if Denied or Ineligible - **Appeal Support:** Case Managers help with denials.[5] - **Other Financial Aid:** Program identifies additional options for eligible patients.[2][3] - **Free Drug Programs:** Contact BioMarin for uninsured/low-income paths (separate from co-pay program). - **Patient Access Foundations:** Organizations like Patient Access Network (PAN) may help with achondroplasia treatments. - **Consult Doctor:** Explore clinical trials or biosimilars (none currently listed).[program data] Call 1-833-869-9646 for guidance. ## Important Disclaimer This guide is for informational purposes only and not a substitute for professional medical or financial advice. Eligibility, benefits, and coverage vary. Program terms can change; confirm with BioMarin RareConnections at 1-833-869-9646 or support@biomarin-rareconnections.com. VOXZOGO has risks—review full Prescribing Information. BioMarin RareConnections data from 2022-2024; individual results may differ. Always consult your healthcare provider.[1][2][3][4]

Program information last verified: March 30, 2026

Ready to apply for VOXZOGO assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications